Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why GW Pharmaceuticals Could Be a Gold Mine for Growth Investors


Why GW Pharmaceuticals Could Be a Gold Mine for Growth Investors

You've probably heard of the great California gold rush of the mid-19th century. Today, many are flocking to what has been called the "green rush" -- a major wave of money flowing into the marijuana industry. But while many marijuana stocks have taken off, many of them are also extremely volatile and risky.

GW Pharmaceuticals (NASDAQ: GWPH) isn't without risk and volatility. However, the biotech specializing in development of cannabinoid drugs has been a huge winner over the past five years, with its stock soaring more than 1,100%. Here are three reasons why GW Pharmaceuticals could still be a gold mine for growth investors wanting to take part in the "green rush."

Image source: Getty Images.

Continue reading


Source: Fool.com

GW Pharmaceuticals plc ADR Stock

€183.00
0.550%
GW Pharmaceuticals plc ADR gained 0.550% compared to yesterday.

Like: 0
Share

Comments